Literature DB >> 10936420

Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County.

R P Gale1, W Cozen, M T Goodman, F F Wang, L Bernstein.   

Abstract

Chronic lymphocytic leukemia (CLL) is rare in Asians living in Asia and possibly in US Asians. In contrast, CLL is the most common leukemia in whites. The basis for this ethnic and geographic variation is unknown. We compared average annual age-adjusted incidence rates (AAIR) of CLL diagnosed from 1972 to 1995 among Los Angeles County-resident Asians, non-Spanish-surnamed- and Spanish-surnamed whites (non-Hispanic and Hispanic-whites) and blacks using the University Southern California-Cancer Surveillance Program (USC-CSP), the population-based cancer registry for Los Angeles County. Asian groups studied included Chinese, Japanese, Filipinos and Koreans. Expected numbers of CLL cases were based on the age-adjusted incidence rates in non-Hispanic whites and compared to numbers of cases observed in Chinese, Japanese and Filipinos. Possible association of socioeconomic state (SES) was assessed using AAIRs with SES-specific denominators. In the absence of denominators by birthplace, the association of birthplace and CLL-incidence was evaluated using proportional odds ratios (POR). Los Angeles County Asian males and females had significantly lower AAIRs than non-Hispanic whites (males: AAIR=0.7 per 100000 population, 95% confidence interval (CI), 0.5-1.0 vs. 4.4, 95% CI, 4.3-4.6; and females: AAIR=0.5, 95% CI, 0.3-0.7 vs. 2.3, 95% CI, 2.2-2.4). Fewer Japanese Chinese and Filipinos were diagnosed with CLL than expected (P<0.01). There was no association of birthplace (POR=0.9, 95% CI, 0. 5-1.9) or SES on CLL-risk. CLL-risk was markedly lower in Los Angeles County Asians compared to non-Hispanic whites. Neither birthplace nor socioeconomic state accounted for this difference suggesting a role for genetic or other environmental factors in decreasing CLL-risk.

Entities:  

Mesh:

Year:  2000        PMID: 10936420     DOI: 10.1016/s0145-2126(00)00038-2

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  15 in total

1.  Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong.

Authors:  Qing Lan; Wing-Yan Au; Stephen Chanock; Jovic Tse; Kit-fai Wong; Min Shen; L P Siu; Jeff Yuenger; Meredith Yeager; Howard Dean Hosgood; Mark P Purdue; Raymond Liang; Nathaniel Rothman
Journal:  Eur J Haematol       Date:  2010-12       Impact factor: 2.997

2.  Ethnic and geographic diversity of chronic lymphocytic leukaemia.

Authors:  Shenmiao Yang; Abraham M Varghese; Nitin Sood; Carlos Chiattone; Norah O Akinola; Xiaojun Huang; Robert Peter Gale
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

3.  Cancer incidence trends among Asian American populations in the United States, 1990-2008.

Authors:  Scarlett Lin Gomez; Anne-Michelle Noone; Daphne Y Lichtensztajn; Steve Scoppa; James T Gibson; Lihua Liu; Cyllene Morris; Sandy Kwong; Kari Fish; Lynne R Wilkens; Marc T Goodman; Dennis Deapen; Barry A Miller
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

4.  Economic evaluation of third-line treatment with alemtuzumab for chronic lymphocytic leukaemia.

Authors:  W Guy Scott; Helen M Scott
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

5.  CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell chronic lymphocytic leukemia (B-CLL).

Authors:  Fiona Pui San Liaw; Lai Ching Lau; Alvin Soon Tiong Lim; Tse Hui Lim; Geok Yee Lee; Sim Leng Tien
Journal:  Int J Hematol       Date:  2014-10-10       Impact factor: 2.490

6.  SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.

Authors:  Takeki Mitsui; Hiromi Koiso; Hirotaka Nakahashi; Akio Saitoh; Hiroaki Shimizu; Takuma Ishizaki; Yoshiyuki Ogawa; Makiko Takizawa; Akihiko Yokohama; Takayuki Saitoh; Takahiro Jinbo; Hidemi Ogura; Hiroshi Handa; Morio Sawamura; Tohru Sakura; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima; Norifumi Tsukamoto
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

Review 7.  Epidemiology and Etiology of Leukemia and Lymphoma.

Authors:  Jordan A Baeker Bispo; Paulo S Pinheiro; Erin K Kobetz
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

8.  Genetic differences between Asian and Caucasian chronic lymphocytic leukemia.

Authors:  Norihiko Kawamata; Chimene Moreilhon; Takayuki Saitoh; Masamitsu Karasawa; Brian K Bernstein; Aiko Sato-Otsubo; Seishi Ogawa; Sophie Raynaud; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2013-05-27       Impact factor: 5.650

9.  Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia.

Authors:  Marilisa Marinelli; Caterina Ilari; Yi Xia; Ilaria Del Giudice; Luciana Cafforio; Irene Della Starza; Sara Raponi; Paola Mariglia; Silvia Bonina; Zhen Yu; Wenjuan Yang; Lugui Qiu; Thomas Chan; Alfonso Piciocchi; Yok-Lam Kwong; Eric Tse; Jianyong Li; Anna Guarini; Wei Xu; Robin Foà
Journal:  Oncotarget       Date:  2016-04-12

10.  Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.

Authors:  Jung-Ah Kim; Byungjin Hwang; Si Nae Park; Sunghoon Huh; Kyongok Im; Sungbin Choi; Hye Yoon Chung; JooRyung Huh; Eul-Ju Seo; Je-Hwan Lee; Duhee Bang; Dong Soon Lee
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.